Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Senzime AB ( (SE:SEZI) ).
Senzime AB has convened its annual general meeting for 19 May 2026 at the company’s premises in Uppsala, setting the record date for shareholder participation as 8 May and the notification deadline as 12 May. The company currently has 157,215,046 shares and votes outstanding, and outlines detailed procedures for registration, nominee-registered holdings and proxy representation.
The proposed agenda includes approval of the 2025 financial statements, discharge of the board and CEO from liability, and decisions on board size, remuneration and auditor election. Shareholders will also vote on new articles of association, a share-based program for board members, a long-term incentive program running to 2030, and a general authorization, measures that could influence Senzime’s capital structure, governance framework and alignment of management and board incentives with shareholder interests.
More about Senzime AB
Senzime AB is a Swedish medical technology company based in Uppsala that develops and markets patient monitoring solutions. The company focuses on advanced monitoring systems designed to improve patient safety and clinical decision-making in healthcare settings, targeting hospitals and surgical care providers in Sweden and internationally.
Average Trading Volume: 222,691
Technical Sentiment Signal: Sell
Current Market Cap: SEK811.2M
Learn more about SEZI stock on TipRanks’ Stock Analysis page.